AI pharmaceutical-development unicorn Deep Intelligent Pharma has recently completed a new financing round of US$60 mill ...

More than 3,200 pharmacists and 30 lecturers from Syria and several Arab and foreign countries are participating in the ...

Pharmaceutical companies breathed a sigh of relief Wednesday after U.S. President Donald Trump revealed that they would not be subject to reciprocal tariffs — but that reprieve could prove fleeting.

India's Piramal Pharma hopes to accelerate earnings growth over the next two to three years, led by rising demand for complex ...

For pharmaceutical and life sciences companies ready to embrace this moment, the 10 principles aren't a burden. They're a ...

Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools ...

The pharma sector to gain from currency tailwinds in the near term, with a weaker rupee acting as a key earnings driver, even ...

LONDON/NEW YORK (Reuters) -Drugmakers are lobbying U.S. President Donald Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the charges and to allow time ...

The Future Career Conversations series, jointly organised by SRM Institute of Science & Technology and The Hindu, will host the sixth webinar in this series, ‘Pharma 2030: Innovation, Regulation and ...

India’s pharmaceutical sector is simultaneously grappling with rising global compliance demands, renewed US trade pressure over patent rules, domestic retail shifts driven by quick-commerce, and state ...

While India has built strong foundations in pharmaceuticals, the next phase of growth will require bold investments, deeper ecosystem collaboration, and a shift towards innovation-led development to p ...